Abstract

Objective: To analyze the association between races/ethnicity and the use of PSA to detect prostate cancer in the US. Method: Observational cross-sectional study. The data used comes from the 2018 Behavioral Risk Surveillance System. Inclusion Criteria: male population residing in the US from Caucasian, African American, and Hispanic race/ethnicity. Exclusion criteria: Men with missing data regarding the variables. Independent variable: race/ethnicity. Dependent variable: Use of the PSA. Confounding Variables: Socioeconomic situation, access to health, information received (advantages, disadvantages, recommendations) about the PSA test by health workers. An adjusted and unadjusted logistic regression was performed calculating odds ratios and a 95% confidence interval. Results: No association was found between race/ethnicity and PSA, OR for Caucasians 1.02 (95% CI 0.95, 1.12), and for Hispanics OR 1.02 (95% CI 0.90, 1.14). The use of the PSA compared to the information received on the advantages of this exam had an OR of 0.19 (95% CI 0.18, 0.20); on disadvantages an OR of 1.06 (95% CI 1.00, 1.13); on recommendations an OR of 0.05 (0.04; 0.05). Access to health and income level had an OR of 0.50 (95% CI 0.46, 0.56) and OR of 1.43 (95% CI 1,36, 1,49), respectively. Conclusions: There was an association between the information provided by health professionals and the use of the PSA, this could encourage the creation of promotional campaigns for the population.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.